CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-09 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-09-09 | Morrison Scott W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-09-09 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-09-09 | ADAMS STREET PARTNERS LLC 10% owner | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-08-20 | MILLER RICHARD A MD President and CEO | Purchase | +10,000 | $1.93 | $19K | 1,288,515 |
| 2021-06-15 | Mitchell Edith P. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-15 | Grais Linda Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-15 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-15 | Morrison Scott W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-15 | Gould Terry P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-15 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-15 | ADAMS STREET PARTNERS LLC 10% owner | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-04 | MILLER RICHARD A MD President and CEO | Purchase | +35,714 | $2.80 | $100K | 35,714 |
| 2021-02-17 | ORBIMED ADVISORS LLC Director | Purchase | +1,285,714 | $3.50 | $4.5M | 8,053,298 |
| 2021-02-17 | Thompson Peter A. Director | Purchase | +1,285,714 | $3.50 | $4.5M | 8,053,298 |
| 2021-02-17 | MILLER RICHARD A MD President and CEO | Purchase | +100,000 | $3.50 | $350K | 1,278,515 |
| 2020-12-16 | Jones William Benton See Remarks | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2020-12-16 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2020-12-16 | MILLER RICHARD A MD President and CEO | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 | ||
| 2020-12-16 | Mobasher Mehrdad SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 |
Page 8 of 15 · 286 trades